{"id":"https://openalex.org/W2899764404","doi":"https://doi.org/10.1200/po.18.00135","title":"Targeted Next-Generation Sequencing Reveals Clinically Actionable BRAF and ESR1 Mutations in Low-Grade Serous Ovarian Carcinoma","display_name":"Targeted Next-Generation Sequencing Reveals Clinically Actionable BRAF and ESR1 Mutations in Low-Grade Serous Ovarian Carcinoma","publication_year":2018,"publication_date":"2018-11-01","ids":{"openalex":"https://openalex.org/W2899764404","doi":"https://doi.org/10.1200/po.18.00135","mag":"2899764404","pmid":"https://pubmed.ncbi.nlm.nih.gov/30828692","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6394870"},"language":"en","primary_location":{"id":"doi:10.1200/po.18.00135","doi":"https://doi.org/10.1200/po.18.00135","is_oa":true,"landing_page_url":"https://doi.org/10.1200/po.18.00135","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/PO.18.00135","source":{"id":"https://openalex.org/S4210227748","display_name":"JCO Precision Oncology","issn_l":"2473-4284","issn":["2473-4284"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCO Precision Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://ascopubs.org/doi/pdfdirect/10.1200/PO.18.00135","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062818691","display_name":"Elizabeth H. Stover","orcid":"https://orcid.org/0000-0002-6578-3216","observed_orcids":["https://orcid.org/0000-0002-6578-3216"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth H. Stover","raw_affiliation_strings":["Elizabeth H. Stover, Ursula A. Matulonis, and Panagiotis A. Konstantinopoulos, Dana-Farber Cancer Institute, Harvard Medical School; and Colleen Feltmate, Ross S. Berkowitz, and Neal I. Lindeman, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA","Dana-Farber Cancer Institute, Harvard Medical School; and","Medical Gynecologic Oncology Program, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston MA 02215;","Merck, Eli Lilly, Geneos, 2X Oncology, Myriad Genetics, Clovis Oncology, Fujifilm Research Funding: Merck, Novartis","Merck, Vertex, AstraZeneca,","Pfizer/EMD Serono"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Elizabeth H. Stover, Ursula A. Matulonis, and Panagiotis A. Konstantinopoulos, Dana-Farber Cancer Institute, Harvard Medical School; and Colleen Feltmate, Ross S. Berkowitz, and Neal I. Lindeman, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579","https://openalex.org/I4210161994"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School; and","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Medical Gynecologic Oncology Program, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston MA 02215;","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Merck, Eli Lilly, Geneos, 2X Oncology, Myriad Genetics, Clovis Oncology, Fujifilm Research Funding: Merck, Novartis","institution_ids":[]},{"raw_affiliation_string":"Merck, Vertex, AstraZeneca,","institution_ids":[]},{"raw_affiliation_string":"Pfizer/EMD Serono","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025921511","display_name":"Colleen M. Feltmate","orcid":"https://orcid.org/0000-0002-7700-8575","observed_orcids":["https://orcid.org/0000-0002-7700-8575"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Colleen Feltmate","raw_affiliation_strings":["Elizabeth H. Stover, Ursula A. Matulonis, and Panagiotis A. Konstantinopoulos, Dana-Farber Cancer Institute, Harvard Medical School; and Colleen Feltmate, Ross S. Berkowitz, and Neal I. Lindeman, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA","Dana-Farber Cancer Institute, Harvard Medical School; and","Medical Gynecologic Oncology Program, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston MA 02215;","Merck, Eli Lilly, Geneos, 2X Oncology, Myriad Genetics, Clovis Oncology, Fujifilm Research Funding: Merck, Novartis","Merck, Vertex, AstraZeneca,","Pfizer/EMD Serono"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Elizabeth H. Stover, Ursula A. Matulonis, and Panagiotis A. Konstantinopoulos, Dana-Farber Cancer Institute, Harvard Medical School; and Colleen Feltmate, Ross S. Berkowitz, and Neal I. Lindeman, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579","https://openalex.org/I4210161994"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School; and","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Medical Gynecologic Oncology Program, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston MA 02215;","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Merck, Eli Lilly, Geneos, 2X Oncology, Myriad Genetics, Clovis Oncology, Fujifilm Research Funding: Merck, Novartis","institution_ids":[]},{"raw_affiliation_string":"Merck, Vertex, AstraZeneca,","institution_ids":[]},{"raw_affiliation_string":"Pfizer/EMD Serono","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086662756","display_name":"Ross Stuart Berkowitz","orcid":"https://orcid.org/0000-0002-7569-898X","observed_orcids":["https://orcid.org/0000-0002-7569-898X"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ross S. Berkowitz","raw_affiliation_strings":["Elizabeth H. Stover, Ursula A. Matulonis, and Panagiotis A. Konstantinopoulos, Dana-Farber Cancer Institute, Harvard Medical School; and Colleen Feltmate, Ross S. Berkowitz, and Neal I. Lindeman, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA","Dana-Farber Cancer Institute, Harvard Medical School; and","Medical Gynecologic Oncology Program, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston MA 02215;","Merck, Eli Lilly, Geneos, 2X Oncology, Myriad Genetics, Clovis Oncology, Fujifilm Research Funding: Merck, Novartis","Merck, Vertex, AstraZeneca,","Pfizer/EMD Serono"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Elizabeth H. Stover, Ursula A. Matulonis, and Panagiotis A. Konstantinopoulos, Dana-Farber Cancer Institute, Harvard Medical School; and Colleen Feltmate, Ross S. Berkowitz, and Neal I. Lindeman, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579","https://openalex.org/I4210161994"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School; and","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Medical Gynecologic Oncology Program, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston MA 02215;","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Merck, Eli Lilly, Geneos, 2X Oncology, Myriad Genetics, Clovis Oncology, Fujifilm Research Funding: Merck, Novartis","institution_ids":[]},{"raw_affiliation_string":"Merck, Vertex, AstraZeneca,","institution_ids":[]},{"raw_affiliation_string":"Pfizer/EMD Serono","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035004148","display_name":"Neal Ian Lindeman","orcid":"https://orcid.org/0000-0002-7092-6859","observed_orcids":["https://orcid.org/0000-0002-7092-6859"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neal I. Lindeman","raw_affiliation_strings":["Elizabeth H. Stover, Ursula A. Matulonis, and Panagiotis A. Konstantinopoulos, Dana-Farber Cancer Institute, Harvard Medical School; and Colleen Feltmate, Ross S. Berkowitz, and Neal I. Lindeman, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA","Dana-Farber Cancer Institute, Harvard Medical School; and","Medical Gynecologic Oncology Program, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston MA 02215;","Merck, Eli Lilly, Geneos, 2X Oncology, Myriad Genetics, Clovis Oncology, Fujifilm Research Funding: Merck, Novartis","Merck, Vertex, AstraZeneca,","Pfizer/EMD Serono"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Elizabeth H. Stover, Ursula A. Matulonis, and Panagiotis A. Konstantinopoulos, Dana-Farber Cancer Institute, Harvard Medical School; and Colleen Feltmate, Ross S. Berkowitz, and Neal I. Lindeman, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579","https://openalex.org/I4210161994"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School; and","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Medical Gynecologic Oncology Program, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston MA 02215;","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Merck, Eli Lilly, Geneos, 2X Oncology, Myriad Genetics, Clovis Oncology, Fujifilm Research Funding: Merck, Novartis","institution_ids":[]},{"raw_affiliation_string":"Merck, Vertex, AstraZeneca,","institution_ids":[]},{"raw_affiliation_string":"Pfizer/EMD Serono","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058249824","display_name":"Ursula A. Matulonis","orcid":"https://orcid.org/0000-0002-3103-6992","observed_orcids":["https://orcid.org/0000-0002-3103-6992"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ursula A. Matulonis","raw_affiliation_strings":["Elizabeth H. Stover, Ursula A. Matulonis, and Panagiotis A. Konstantinopoulos, Dana-Farber Cancer Institute, Harvard Medical School; and Colleen Feltmate, Ross S. Berkowitz, and Neal I. Lindeman, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA","Dana-Farber Cancer Institute, Harvard Medical School; and","Medical Gynecologic Oncology Program, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston MA 02215;","Merck, Eli Lilly, Geneos, 2X Oncology, Myriad Genetics, Clovis Oncology, Fujifilm Research Funding: Merck, Novartis","Merck, Vertex, AstraZeneca,","Pfizer/EMD Serono"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Elizabeth H. Stover, Ursula A. Matulonis, and Panagiotis A. Konstantinopoulos, Dana-Farber Cancer Institute, Harvard Medical School; and Colleen Feltmate, Ross S. Berkowitz, and Neal I. Lindeman, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579","https://openalex.org/I4210161994"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School; and","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Medical Gynecologic Oncology Program, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston MA 02215;","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Merck, Eli Lilly, Geneos, 2X Oncology, Myriad Genetics, Clovis Oncology, Fujifilm Research Funding: Merck, Novartis","institution_ids":[]},{"raw_affiliation_string":"Merck, Vertex, AstraZeneca,","institution_ids":[]},{"raw_affiliation_string":"Pfizer/EMD Serono","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076246054","display_name":"Panagiotis A. Konstantinopoulos","orcid":"https://orcid.org/0000-0002-1032-1479","observed_orcids":["https://orcid.org/0000-0002-1032-1479"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Panagiotis A. Konstantinopoulos","raw_affiliation_strings":["Elizabeth H. Stover, Ursula A. Matulonis, and Panagiotis A. Konstantinopoulos, Dana-Farber Cancer Institute, Harvard Medical School; and Colleen Feltmate, Ross S. Berkowitz, and Neal I. Lindeman, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA","Dana-Farber Cancer Institute, Harvard Medical School; and","Medical Gynecologic Oncology Program, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston MA 02215;","Merck, Eli Lilly, Geneos, 2X Oncology, Myriad Genetics, Clovis Oncology, Fujifilm Research Funding: Merck, Novartis","Merck, Vertex, AstraZeneca,","Pfizer/EMD Serono"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Elizabeth H. Stover, Ursula A. Matulonis, and Panagiotis A. Konstantinopoulos, Dana-Farber Cancer Institute, Harvard Medical School; and Colleen Feltmate, Ross S. Berkowitz, and Neal I. Lindeman, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579","https://openalex.org/I4210161994"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School; and","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Medical Gynecologic Oncology Program, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston MA 02215;","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Merck, Eli Lilly, Geneos, 2X Oncology, Myriad Genetics, Clovis Oncology, Fujifilm Research Funding: Merck, Novartis","institution_ids":[]},{"raw_affiliation_string":"Merck, Vertex, AstraZeneca,","institution_ids":[]},{"raw_affiliation_string":"Pfizer/EMD Serono","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5076246054"],"corresponding_institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579","https://openalex.org/I4210161994"],"apc_list":null,"apc_paid":null,"fwci":1.6089,"has_fulltext":true,"cited_by_count":12,"citation_normalized_percentile":{"value":0.83339188,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"2018","issue":"2","first_page":"1","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.8647000193595886,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.8647000193595886,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.13279999792575836,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10390","display_name":"Ovarian function and disorders","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/low-grade-serous-ovarian-carcinoma","display_name":"low-grade serous ovarian cancer","score":0.9359999895095825},{"id":"https://openalex.org/keywords/braf-mutation","display_name":"BRAF mutation","score":0.8379999995231628},{"id":"https://openalex.org/keywords/esr1-mutations","display_name":"ESR1 mutations","score":0.9980000257492065},{"id":"https://openalex.org/keywords/targeted-next-generation-sequencing","display_name":"targeted next-generation sequencing","score":0.8309999704360962},{"id":"https://openalex.org/keywords/precision-oncology","display_name":"precision oncology","score":0.7429999709129333},{"id":"https://openalex.org/keywords/molecular-subtyping","display_name":"molecular subtyping","score":0.40799999237060547}],"concepts":[{"id":"https://openalex.org/C3019054536","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian carcinoma","level":4,"score":0.593418300151825},{"id":"https://openalex.org/C150173356","wikidata":"https://www.wikidata.org/wiki/Q6144101","display_name":"Serous fluid","level":2,"score":0.5449501276016235},{"id":"https://openalex.org/C51679486","wikidata":"https://www.wikidata.org/wiki/Q380546","display_name":"DNA sequencing","level":3,"score":0.4964445233345032},{"id":"https://openalex.org/C2777632260","wikidata":"https://www.wikidata.org/wiki/Q19000698","display_name":"Serous carcinoma","level":4,"score":0.45644599199295044},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.44061851501464844},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4330090880393982},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.41526076197624207},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.37744206190109253},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3550676703453064},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.34431231021881104},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.3046441972255707},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.25033318996429443},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.20747992396354675},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.16686686873435974}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1200/po.18.00135","doi":"https://doi.org/10.1200/po.18.00135","is_oa":true,"landing_page_url":"https://doi.org/10.1200/po.18.00135","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/PO.18.00135","source":{"id":"https://openalex.org/S4210227748","display_name":"JCO Precision Oncology","issn_l":"2473-4284","issn":["2473-4284"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCO Precision Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6394870","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6394870","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCO Precis Oncol","raw_type":"Text"},{"id":"pmid:30828692","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30828692","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCO precision oncology","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:5388276","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC6394870","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1200/po.18.00135","doi":"https://doi.org/10.1200/po.18.00135","is_oa":true,"landing_page_url":"https://doi.org/10.1200/po.18.00135","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/PO.18.00135","source":{"id":"https://openalex.org/S4210227748","display_name":"JCO Precision Oncology","issn_l":"2473-4284","issn":["2473-4284"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCO Precision Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1485268950","display_name":null,"funder_award_id":"TR001100","funder_id":"https://openalex.org/F4320337472","funder_display_name":"National Center for Advancing Translational Sciences"},{"id":"https://openalex.org/G5457525012","display_name":null,"funder_award_id":"KL2 TR001100","funder_id":"https://openalex.org/F4320309673","funder_display_name":"Harvard Catalyst"},{"id":"https://openalex.org/G7482061296","display_name":"Harvard Clinical and Translational Science Center","funder_award_id":"KL2TR001100","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G994665467","display_name":null,"funder_award_id":"TR001100","funder_id":"https://openalex.org/F4320309673","funder_display_name":"Harvard Catalyst"}],"funders":[{"id":"https://openalex.org/F4320309673","display_name":"Harvard Catalyst","ror":null},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337472","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2899764404.pdf","grobid_xml":"https://content.openalex.org/works/W2899764404.grobid-xml"},"referenced_works_count":42,"referenced_works":["https://openalex.org/W779403461","https://openalex.org/W1464936406","https://openalex.org/W1601126056","https://openalex.org/W1812690400","https://openalex.org/W1825430271","https://openalex.org/W1846586690","https://openalex.org/W1897736663","https://openalex.org/W1964431433","https://openalex.org/W2003929214","https://openalex.org/W2014881369","https://openalex.org/W2021145743","https://openalex.org/W2033670530","https://openalex.org/W2057058351","https://openalex.org/W2061451800","https://openalex.org/W2073367400","https://openalex.org/W2076623927","https://openalex.org/W2091107854","https://openalex.org/W2102962435","https://openalex.org/W2111324624","https://openalex.org/W2114852376","https://openalex.org/W2127037900","https://openalex.org/W2130940380","https://openalex.org/W2137332694","https://openalex.org/W2167188058","https://openalex.org/W2179105349","https://openalex.org/W2224210111","https://openalex.org/W2332737325","https://openalex.org/W2346330132","https://openalex.org/W2415372857","https://openalex.org/W2514365970","https://openalex.org/W2515153451","https://openalex.org/W2551013093","https://openalex.org/W2554965207","https://openalex.org/W2565707423","https://openalex.org/W2569695585","https://openalex.org/W2589778279","https://openalex.org/W2589882759","https://openalex.org/W2590528754","https://openalex.org/W2594059953","https://openalex.org/W2614443510","https://openalex.org/W2653933210","https://openalex.org/W4298324324"],"related_works":["https://openalex.org/W4210636185","https://openalex.org/W4362730163","https://openalex.org/W2014680685","https://openalex.org/W2808106298","https://openalex.org/W4301826359","https://openalex.org/W2507861992","https://openalex.org/W4286298157","https://openalex.org/W2942955148","https://openalex.org/W4312193701","https://openalex.org/W3174690793"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2018-11-16T00:00:00"}